Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Behav Ther. 2020 Sep 1;52(3):639–655. doi: 10.1016/j.beth.2020.08.003

Table 4.

Benchmarked Sample Characteristics, Treatment Feasibility, Treatment Acceptability, and Adherence Outcomes

Effectiveness Trial (Current Study) Efficacy Trial #1 (Harned et al., 2014) Efficacy Trial #2 (Harned et al., 2012) Effectiveness vs. Efficacy #1 Effectiveness vs. Efficacy #2
(N = 35) (n = 17) (n = 13) ES ES
Sample Demographics
 Age, M (SD) 29.9 (13.2) 33.2 (13.1) 39.4 (11.4) −0.2 −0.7*
 Female 80.0 100.0 100.0 0.3* 0.2
 Racial/ethnic minority 64.7 23.5 30.8 0.4** 0.3*
 Sexual minority 44.1 12.5 53.8 0.3* 0.1
 Highest education high school or less 60.0 17.6 38.5 0.4** 0.2
 Annual income <$5,000 84.8 31.3 36.4 0.5*** 0.5**
Treatment Feasibility and Safety
 Tx ended due to patient dropout 28.6 41.2 23.1 0.1 −0.1
 Tx ended for other reasons 25.7 0 0 −0.3* −0.3*
 Received one year of treatment 45.7 58.8 76.9 −0.1 −0.3*
 Initiated DBT PE 45.7 47.1 76.9 0.0 −0.3
 Completed DBT PEa 56.3 75.0 70.0 −0.2 −0.1
 # of DBT PE sessionsb, M (SD) 9.8 (4.2) 12.7 (2.9) 13.0 (4.5) −0.7 −0.7
 Any SIB during DBT PEa 20.0 25.0 20.0 0.1 0.0
Treatment Acceptability
 Preference for DBT PE (pre) 82.9 82.4 76.9 0.0 0.1
 Patient expectancies (pre), M (SD) 6.4 (0.6) 6.4 (0.6) 6.5 (0.4) 0.0 −0.1
 Clinician expectancies (pre), M (SD) 6.2 (0.6) 6.2 (0.7) 6.1 (1.4) 0.0 0.1
 Patient satisfaction (post)a, M (SD) 27.2 (3.2) 27.0 (6.9) 29.6 (2.4) 0.0 −0.8
Treatment Adherence
 DBT adherence, M (SD) 3.9 (0.2) 4.1 (0.2) - −0.9*** -
 DBT PE adherencea, M (SD) 2.7 (0.6) 2.9 (0.2) - −0.4 -

Note. Data are given as percentages and are based on the intent-to-treat samples unless otherwise indicated. Between-group effect sizes (ES) are Hedge’s g for continuous outcomes and Cohen’s w for categorical outcomes. For Hedge’s g, small effect = 0.2, medium effect = 0.5, large effect = 0.8. For Cohen’s w, small effect = 0.1, medium effect = 0.3, large effect = 0.5. Negative between-group effect sizes indicate poorer outcomes in the current effectiveness trial than in the benchmarked efficacy trial and comparisons were conducted using t-tests for continuous outcomes and chi-squares for categorical outcomes. DBT PE = Dialectical Behavior Therapy Prolonged Exposure protocol. Tx = treatment. SIB = self-injurious behavior.

a

Among patients who initiated DBT PE.

b

Among patients who completed DBT PE.

*

p < .05,

**

p < .01,

***

p < .001.